Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis

Infection and Immunity

Volumn 70, Issue 6, 2002, Pages 3080-3084

  Gordhan, Bhavna G ^a   Smith, Debbie A ^a   Alderton, Heidi ^a   McAdam, Ruth A ^a   Bancroft, Gregory J ^a   Mizrahi, Valerie ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININOSUCCINATE SYNTHASE; CITRULLINE;

ARTICLE; AUXOTROPHIC MUTANT; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BIOSYNTHESIS; GROWTH RATE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; STRAIN DIFFERENCE;

ANIMALS; ARGININE; DISEASE MODELS, ANIMAL; IMMUNOCOMPETENCE; KINETICS; MICE; MICE, INBRED DBA; MICE, SCID; MUTAGENESIS; MYCOBACTERIUM TUBERCULOSIS; ORNITHINE CARBAMOYLTRANSFERASE; PHENOTYPE; SUBSTRATE SPECIFICITY; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 0036266673     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.6.3080-3084.2002     Document Type: Article

References (25)

1. Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages
2. Arginase modulates nitric oxide production in activated macrophages
3. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
4. Biosynthesis and metabolism of arginine in bacteria
5. Biosynthesis of arginine and polyamines
6. Construction by homologous recombination and phenotypic characterization of a polA mutant of Mycobacterium smegmatis
7. Gene replacement using pretreated DNA
8. Auxotrophic vaccines for tuberculosis
9. Enhanced gene replacement in mycobacteria
10. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis
11. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine
12. Five Listeria monocytogenes genes preferentially expressed in infected mammalian cells: plcA, purH, purD, pyrE, and an arginine ABC transporter, argJ
13. Selection of bacterial virulence genes that are specifically induced in host tissues
14. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis
15. Nitric oxide as a secretory product of mammalian cells
16. Mycobacterial virulence: Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity
17. Production of mutants in amino acid biosynthetic genes of Mycobacterium tuberculosis by homologous recombination
18. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement
19. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis Bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange
20. Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors
21. Effects of Mycobacterium bovis BCG infection on regulation of L-arginine uptake and synthesis of reactive nitrogen intermediates in J774.1 murine macrophages
22. Amino acid transport and metabolism in mycobacteria: Cloning, interruption, and characterization of an L-arginine/-γaminobutyric acid permease in Mycobacterium bovis BCG
23. Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates
24. Molecular cloning, characterization and purification of ornithine carbamoyltransferase from Mycobacterium bovis BCG
25. Arginine metabolism: Nitric oxide and beyond